A vaccination for tuberculosis (TB) is called Bacille Calmette-Guérin (BCG). In the US, Human Tuberculosis Vaccine is not frequently utilised. However, in other nations where TB is widespread, it is frequently administered to babies and young children. BCG does not always shield individuals from contracting TB. Only those who meet particular requirements and in consultation with a TB expert are given the option of receiving BCG in the United States. If medical professionals have any queries regarding BCG vaccination for their patients, they should contact their state's or region's TB control programme.
In circumstances where there is a high risk of infection, health care professionals should be given the BCG vaccine on an individual basis.
Infection with TB strains that are resistant to both isoniazid and rifampin affects a large proportion of TB patients; continuous transfer of drug-resistant TB strains to healthcare personnel increases the risk of further infection;
Although extensive TB infection control measures have been put in place, they have not proved effective.
The dangers and advantages of both the BCG vaccine and the treatment of latent TB infection should be discussed with healthcare personnel who are considering becoming vaccinated against BCG.
Read More- https://cmiblogdailydose.blogspot.com/2022/12/human-tuberculosis-vaccine-is-used-to.html
